-+ 0.00%
-+ 0.00%
-+ 0.00%

Jazz Pharmaceuticals unit launches private offering of $1 billion exchangeable senior notes due 2032

PUBT·08/31/2026 21:23:24
Listen to the news
Jazz Pharmaceuticals unit launches private offering of $1 billion exchangeable senior notes due 2032
  • Jazz Pharmaceuticals announced a private offering of USD 1 billion exchangeable senior notes due 2032.
  • Initial purchasers get a 13-day option to buy up to an additional USD 150 million of the notes.
  • Net proceeds earmarked for general corporate purposes.
  • Concurrent plan to repurchase up to USD 225 million of ordinary shares from note buyers using cash on hand.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jazz Pharmaceuticals plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-377073), on August 31, 2026, and is solely responsible for the information contained therein.